Cibus (CBUS) vs vTv Therapeutics (VTVT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
vTv Therapeutics (VTVT) has outperformed Cibus (CBUS) over the past year, gaining 37.5% versus a gain of 13.3%. Over five years, VTVT leads with a -47.3% price change compared with -98.9% for CBUS. Cibus is the larger company by market cap ($121.5 million vs $118.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBUS | VTVT |
|---|---|---|
| Share price | $1.59 | $30.08 |
| Market cap | $121.52M | $118.93M |
| 1-day change | -1.85% | -3.00% |
| YTD return | -6.90% | -22.46% |
| 1-year return | +13.29% | +37.52% |
| 5-year return | -98.90% | -47.26% |
| EPS (TTM) | $-1.62 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.19 | $44.00 |
| 52-week low | $1.09 | $19.50 |
| Distance from 52-week high | -62.06% | -31.64% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +801.26% | +81.88% |
| Average volume | 206.34K | 67.89K |
| Shares outstanding | 76.43M | 3.95M |
| Employees | 118 | 26 |
| Sector | Industrials | Health Care |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- VTVT has outperformed CBUS by 24.2 percentage points over the past year.
- The two companies sit in different sectors: Cibus in Industrials and vTv Therapeutics in Health Care.
About Cibus
CBUS stock →Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Industrials · Agricultural Chemicals · 118 employees
About vTv Therapeutics
VTVT stock →vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 26 employees
CBUS vs VTVT FAQ
Which is bigger, Cibus or vTv Therapeutics?
Cibus (CBUS) is larger, with a market capitalization of $121.52M compared with $118.93M for vTv Therapeutics (VTVT).
Which stock has performed better over the past year, CBUS or VTVT?
VTVT returned +37.52% over the past 12 months, compared with +13.29% for CBUS (price return, excluding dividends). Past performance does not predict future results.
Are Cibus and vTv Therapeutics in the same industry?
No. Cibus is in the Industrials sector, while vTv Therapeutics is in Health Care.